Moscona, A. Neuraminidase inhibitors for influenza. N. Engl. J. Med.
353 (2005) 1363–1367.
Article
PubMed
CAS
Google Scholar
Matrosovich, M.N., Matrosovitch, T.Y., Gray, T, Roberts, N.A. and Klenk, H.D. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J. Virol.
78 (2004) 12665–12667.
Article
PubMed
CAS
Google Scholar
Gubareva, L.V., Kaiser, L. and Hayden, F.G. Influenza virus neuraminidase inhibitors. Lancet
355 (2000) 827–835.
Article
PubMed
CAS
Google Scholar
Englund, J.A. Antiviral therapy of influenza. Sem. in Ped. Infect. Dis.
13 (2002) 120–128.
Article
Google Scholar
Stiver, G. The treatment of influenza with antiviral drugs. CMAJ
168 (2003) 49–57.
PubMed
Google Scholar
Colman, P.M. A novel approach to antiviral therapy for influenza. J. Antimicrob. Chemother.
44 (1999) 17–22.
Article
PubMed
CAS
Google Scholar
Brandtzaeg, P., Farstad, I.N., Johansen, F.E., Morton, H.C., Norderhaug, I.N. and Yamanaka, T. The B-cell system of human mucosae and exocrine glands. Immunol. Rev.
171 (1999) 45–87.
Article
PubMed
CAS
Google Scholar
Tomana, M., Kulhavy, R. and Mestecky, J. Receptor-mediated binding and uptake of IgA by human liver. Gastroenterology
94 (1988) 762–770.
PubMed
CAS
Google Scholar
Groh, V., Porcelli, S., Fabbi, M., Lanier, L.L., Picker, L.J., Anderson, T., Warnke, R.A., Bhan, A.K., Strominger, J.L. and Brenner, M.B. Human lymphocyes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system. J. Exp. Med.
169 (1989) 1277–1294.
Article
PubMed
CAS
Google Scholar
Spencer, J., Isaacson, P.G., Diss, T.C. and MacDonald, T.T. Expression of disulfide-linked and non-disulfide-linked forms of the T cell receptor gamma/delta heterodimer in human intestinal intraepithelial lymphocytes. Eur. J. Immunol.
19 (1989) 1335–1338.
PubMed
CAS
Google Scholar
Deusch, K., Luling, F., Reich, K., Classen, M., Wagner, H. and Pfeffer, K.A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta1 gene segment. Eur. J. Immunol.
21 (1991) 1053–1059.
PubMed
CAS
Google Scholar
Jones, W.M., Walcheck, B. and Jutila, M.A. Generation of a new gamma/delta T cell-specific monoclonal antibody (GD3.5). J. Immunol.
156 (1996) 3772–3779.
PubMed
CAS
Google Scholar
Floyd, H., Nitschke, L. and Crocker, P.R. A novel subset of murine B cells that expresses unmasked forms of CD22 is enriched in the bone marrow: Implications for B-cell homing to the bone marrow. Immunology
101 (2000) 342–347.
Article
PubMed
CAS
Google Scholar
Nitschke, L., Floyd, H. and Ferguson, D.J., Identification of CD22 ligands on CD22 bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B-cells. J. Exp. Med.
189 (1999) 1513–1518.
Article
PubMed
CAS
Google Scholar
Reinholdt, J., Tomana, M. and Mortensen, S.B. Molecular aspects of IgA degredation by oral streptococci. Infect. Immunol.
58 (1990) 1186–1194.
CAS
Google Scholar
Kast R.E. A theory of lymphocyte blast transformation and malignant change based on proteolytic cleavage of the trigger peptide: The detendomer. Oncology
29 (1974) 249–264.
Article
PubMed
CAS
Google Scholar
Kast, R.E. Lymphocytes and cells in malignant transformation. Oncology
32 (1975) 175–189.
PubMed
CAS
Google Scholar
Gronbaek Frandsen, E.V. Bacterial degradation of IgA1 in relation to periodontal disease. APMIS (Suppl) 87 (1999) 1–54.
CAS
Google Scholar
King, S.J., Hippe, K.R., Gould, J.M., Bae, D., Peterson, S., Cline, R.T., Fasching, C., Janoff, E.N. and Weiser, J.N. Phase variable desialylation of host proteins that bind to Streptococcus pneumoniae in vivo and protect the airway. Mol. Microbiol.
54 (2004) 159–171.
Article
PubMed
CAS
Google Scholar
Kannagi, R. Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes. Curr. Opin. Struct. Biol.
12 (2002) 599–608.
Article
PubMed
CAS
Google Scholar
Glezen, W.P., Payne, A.A. and Snyder, D.N. Mortality and influenza. J. Infect. Dis.
146 (1982) 313–321.
PubMed
CAS
Google Scholar
Simonsen, L, Fukada, K. and Schonberger, L.B. The impact of influenza epidemics on hospitalizations. J. Infect. Dis.
181 (2000) 831–837.
Article
PubMed
CAS
Google Scholar
Simonsen, L. The global impact of influenza on morbidity and mortality. Vaccine
17 (Suppl 1) (1999) S3–10.
Article
PubMed
Google Scholar
McCullers, J.A. and Bartmess, K.C. Role of neauraminidase in lethal synergism between influenza virus and streptococcus pneumoniae. J. Infect. Dis.
187 (2003) 1000–1009.
Article
PubMed
CAS
Google Scholar
McCullers, J.A. Effect of antiviral treatment on the outcome of secondary bacterial pneumonia after influenza. J. Infect. Dis.
190 (2004) 519–526.
Article
PubMed
CAS
Google Scholar
Kaiser, L., Wat, C., Mills, T., Mahoney, P., Ward, P. and Hayden, F. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations. Arch. Intern. Med.
163 (2003) 1667–1672.
Article
PubMed
CAS
Google Scholar
Kaiser, L., Keene, O.N. and Hammond, J.M. Impact of zanamivir on antibiotic use for respiratory events following acute influenza in adolescents and adults. Arch Intern Med
160 (2000) 3234–3240.
Article
PubMed
CAS
Google Scholar
Treanor, J.J., Hayden, F.G., Vrooman, P.S., Barbarash, R., Bettis, R., Riff, D., Singh, S., Kinnersley, N., Ward, P. and Mills, R.G. Efficacy and safety of oral neuraminidase Inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. JAMA
283 (2000) 1016–1024.
Article
PubMed
CAS
Google Scholar
Monto, A.S., Webster, A. and Keene, O. Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: Pooled efficacy analysis. J. Antimicrob. Chemother.
44 (1999) 23–29.
Article
PubMed
CAS
Google Scholar
Peltola, V.T., Murti, K.G. and McCullers, J.A. Influenza virus neuraminidase contributes to secondary bacterial pneumonia. J Infect Dis.
192 (2005) 249–257.
Article
PubMed
CAS
Google Scholar
Peltola, V.T. and McCullers, J.A. Respiratory viruses predisposing to bacterial infections: role of neuraminidase. Pediatr. Infect. Dis. J.
23 (Suppl.1) (2004) S87–97.
Article
PubMed
Google Scholar
Yen, H.L., Herlocher, L.M., Hoffmann, E., Matrosovich, M.N., Monto, A.S., Webster, R.G. and Govorkova, E.A. Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob. Agents Chemother.
49 (2005) 4075–4084.
Article
PubMed
CAS
Google Scholar
Roberts, N. Treatment of influenza with neuraminidase inhibitors: Virological implications. Phil. Trans. R. Soc. Lond.
356 (2001) 1895–1897.
Article
CAS
Google Scholar
Wakai, K., Nakai, S., Matsuo, S., Kawamura, T., Hotta, N., Maeda, K. and Ohno, Y. Risk factors for IgA nephropathy: A case-control study with incident cases in Japan. Nephron
90 (2002) 16–23.
Article
PubMed
Google Scholar
Xu, L.X. and Zhao, M.H. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int.
68 (2005) 167–172.
Article
PubMed
CAS
Google Scholar
Altschuler, E.L., Bhatia, A. and Kast, R.E. Consideration of use of neuraminidase inhibitors such as oseltamivir and zanamivir in IgA nephropathy. Kidney Int.
68 (2005) 2910–2911.
Article
PubMed
Google Scholar